PCSAProcessa Pharmaceuticals, Inc.

Nasdaq processapharmaceuticals.com


$ 2.20 $ -0.09 (-3.98 %)    

Friday, 03-May-2024 15:59:45 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 2.17
$ 2.18
$ 0.00 x 0
$ 0.00 x 0
$ 2.18 - $ 2.20
$ 1.40 - $ 18.00
91,438
na
2.85M
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-06-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-28-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-21-2018 03-31-2018 10-Q
25 04-16-2018 12-31-2017 10-K
26 11-20-2017 09-30-2017 10-Q
27 10-04-2017 06-30-2017 10-Q
28 10-04-2017 03-31-2017 10-Q
29 09-25-2017 12-31-2016 10-K
30 09-08-2017 09-30-2016 10-Q
31 08-30-2017 06-30-2016 10-Q
32 08-07-2017 03-31-2016 10-Q
33 06-19-2017 12-31-2015 10-K
34 12-01-2015 09-30-2015 10-Q
35 08-19-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 04-14-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-19-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-initiates-coverage-on-processa-pharma-with-buy-rating-announces-price-target-of-8

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Processa Pharma (NASDAQ:PCSA) with a Buy rating and...

 benchmark-reiterates-speculative-buy-on-processa-pharma-maintains-4-price-target

Benchmark analyst Robert Wasserman reiterates Processa Pharma (NASDAQ:PCSA) with a Speculative Buy and maintains $4 price ta...

 processa-pharmaceuticals-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their ...

 expensify-and-3-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates thei...

 relmada-therapeutics-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates thei...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION